NasdaqCM - Delayed Quote USD
Mereo BioPharma Group plc (MREO)
2.6500
+0.1000
+(3.92%)
At close: 4:00:01 PM EDT
2.6500
0.00
(0.00%)
After hours: 4:04:12 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 7.66M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEWICKI JOHN A Officer | Sale at price 4.22 - 4.47 per share. | Direct | 69,477 | Sep 13, 2024 |
| SERMON CHARLES E. General Counsel | Sale at price 4.22 - 4.47 per share. | Direct | 133,051 | Sep 13, 2024 |
| SCOTS-KNIGHT DENISE Chief Executive Officer | Sale at price 4.22 - 4.47 per share. | Direct | 381,423 | Sep 13, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | Sale at price 4.22 - 4.47 per share. | Direct | 637,203 | Sep 13, 2024 |
| FOX CHRISTINE ANN Chief Financial Officer | Sale at price 4.22 - 4.47 per share. | Direct | 121,693 | Sep 13, 2024 |
| LEWICKI JOHN A Officer | -- | Direct | -- | Sep 11, 2024 |
| SERMON CHARLES E. General Counsel | -- | Direct | -- | Sep 11, 2024 |
| SCOTS-KNIGHT DENISE Chief Executive Officer | -- | Direct | -- | Sep 11, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | Conversion of Exercise of derivative security at price 1.01 - 1.40 per share. | Direct | 206,416 | Sep 11, 2024 |
| FOX CHRISTINE ANN Chief Financial Officer | -- | Direct | -- | Sep 11, 2024 |
| PAKIANATHAN DEEPIKA R Director | Sale at price 4.43 per share. | Direct | 466,210 | Aug 22, 2024 |
| PAKIANATHAN DEEPIKA R Director | Conversion of Exercise of derivative security at price 0.94 - 3.87 per share. | Direct | 151,116 | Aug 22, 2024 |
| LEWICKI JOHN A Officer | Sale at price 3.39 - 3.69 per share. | Direct | 84,427 | Jun 26, 2024 |
| SERMON CHARLES E. General Counsel | Sale at price 3.39 - 3.69 per share. | Direct | 161,678 | Jun 26, 2024 |
| SCOTS-KNIGHT DENISE Chief Executive Officer | Sale at price 3.39 - 3.69 per share. | Direct | 463,487 | Jun 26, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | Sale at price 3.39 - 3.69 per share. | Direct | 115,369 | Jun 26, 2024 |
| FOX CHRISTINE ANN Chief Financial Officer | Sale at price 3.39 - 3.69 per share. | Direct | 147,876 | Jun 26, 2024 |
| LEWICKI JOHN A Officer | -- | Direct | -- | Jun 21, 2024 |
| SERMON CHARLES E. General Counsel | -- | Direct | -- | Jun 21, 2024 |
| SCOTS-KNIGHT DENISE Chief Executive Officer | -- | Direct | -- | Jun 21, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | -- | Direct | -- | Jun 21, 2024 |
| FOX CHRISTINE ANN Chief Financial Officer | -- | Direct | -- | Jun 21, 2024 |
| WYZGA MICHAEL S Director | Stock Award(Grant) at price 3.99 per share. | Direct | 99,950 | Jun 17, 2024 |
| BENDER JEREMY Director | Stock Award(Grant) at price 3.99 per share. | Indirect | 50,074 | Jun 17, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | Sale at price 2.94 - 2.99 per share. | Direct | 297,788 | May 22, 2024 |
| HUGHES-WILSON ALEXANDRA Officer | Conversion of Exercise of derivative security at price 1.01 - 1.40 per share. | Direct | 206,416 | May 22, 2024 |
Related Tickers
PDSB PDS Biotechnology Corporation
1.5300
+8.51%
RARE Ultragenyx Pharmaceutical Inc.
36.40
+0.72%
DAWN Day One Biopharmaceuticals, Inc.
6.98
-0.43%
TRVI Trevi Therapeutics, Inc.
5.95
-5.78%
MLTX MoonLake Immunotherapeutics
48.55
+17.95%
LXEO Lexeo Therapeutics, Inc.
2.8200
+3.68%
OCUL Ocular Therapeutix, Inc.
8.33
+2.71%
NKTR Nektar Therapeutics
0.7495
-5.89%
XFOR X4 Pharmaceuticals, Inc.
3.9600
+3.94%
LPTX Leap Therapeutics, Inc.
0.3705
+3.35%